Bharat Biotech gets DCGI's nod to conduct intranasal booster dose trials
March 26, 2023
  • Circulation
  • Advertise
  • Careers
  • About Us
  • Contact Us
Organiser
  • ‌
  • Bharat
  • World
  • G20
  • Editorial
  • Analysis
  • Opinion
  • Sports
  • More
    • Defence
    • RSS in News
    • Azadi Ka Amrit Mahotsav
    • My States
    • Vocal4Local
    • Business
    • Special Report
    • Culture
    • Sci & Tech
    • Entertainment
    • Education
    • Books
    • Interviews
    • Travel
    • Health
    • Obituary
SUBSCRIBE
No Result
View All Result
  • ‌
  • Bharat
  • World
  • G20
  • Editorial
  • Analysis
  • Opinion
  • Sports
  • More
    • Defence
    • RSS in News
    • Azadi Ka Amrit Mahotsav
    • My States
    • Vocal4Local
    • Business
    • Special Report
    • Culture
    • Sci & Tech
    • Entertainment
    • Education
    • Books
    • Interviews
    • Travel
    • Health
    • Obituary
No Result
View All Result
Organiser
No Result
View All Result
  • Home
  • Bharat
  • World
  • G20
  • Editorial
  • Opinion
  • Analysis
  • Culture
  • Defence
  • RSS in News
  • My States
  • Vocal4Local
  • Subscribe
Home Bharat

Bharat Biotech gets DCGI’s nod to conduct intranasal booster dose trials

WEB DESK by WEB DESK
Jan 28, 2022, 04:29 pm IST
in Bharat, Delhi, Health
Share on FacebookShare on TwitterTelegramEmail

New Delhi: The Drugs Controller General of India (DCGI) on Friday granted permission to Bharat Biotech to conduct clinical trials of intranasal vaccine BBV154.

The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) had also recommended the internasal vaccine clinical trials during the last meeting.

The NOC letter issued by the DCGI read, "Central Licensing Authority hereby permits Bharat Biotech International limited to conduct clinical trials of the new drug or investigational new drug."

The dosage form of the vaccine is liquid for the intranasal route of administration and every single dose contains 0.5ml.

The trials of the Intranasal vaccine will take place at nine different sites of the country.

The trials will be conducted at Atman Hospital, Ahmedabad, Gujarat; AIIMS, Delhi and Patna; Oyster and Pearls Hospitals, Pune; Pt.BD Sharma Postgraduate Institute of Medical Sciences at Rohtak, Haryana; Acharya Vinobha Bhave Rural Hospital, Wardha; Jeevan Rekha Hospital, Belagavi; Rana hospital, Gorakhpur; and Prakhar Hospital, Uttar Pradesh.

"The Phase -3 clinical trial should be conducted as per protocol multi-center study to compare immunogenicity and safety of BBV154 with COVAXIN." read the letter. (ANI)

ShareTweetSendShareSend
Previous News

Assam: Police arrested Burhanuddin, Gulzar and Safiqul while trying to smuggle cows; Police recovered 58 cows on their way to the slaughterhouse

Next News

Gujarat Model: A Template For Growth

Related News

Assam: Massive rally over the issue of anti-conversion and delisting of ST status organised by JDSSM, more than 55000 tribals participated

Assam: Massive rally over the issue of anti-conversion and delisting of ST status organised by JDSSM, more than 55000 tribals participated

Bihar: Row over ‘Hindu Rashtra’ banners in Darbhanga, VHP slams Nitish-Tejashwi Government for lodging FIR

Hindu Rashtra Flags: Bihar police arrested VHP district secretary after flags appeared in Darbhanga

Land For Job Scam: Tejashwi Yadav finally presented before the CBI

Land For Job Scam: Tejashwi Yadav finally presented before the CBI

Demographic Shift of Europe: Spain witnessed 10 times increase in Muslim Population in last 3 decades

Demographic Shift of Europe: Spain witnessed 10 times increase in Muslim Population in last 3 decades

Organ donation by one person can give life to 8-9 people: PM Modi in ‘Mann Ki Baat’

Organ donation by one person can give life to 8-9 people: PM Modi in ‘Mann Ki Baat’

ISRO launches India’s largest LVM3 rocket from Sriharikota

ISRO launches India’s largest LVM3 rocket from Sriharikota

Comments

The comments posted here/below/in the given space are not on behalf of Organiser. The person posting the comment will be in sole ownership of its responsibility. According to the central government's IT rules, obscene or offensive statement made against a person, religion, community or nation is a punishable offense, and legal action would be taken against people who indulge in such activities.

Latest News

Assam: Massive rally over the issue of anti-conversion and delisting of ST status organised by JDSSM, more than 55000 tribals participated

Assam: Massive rally over the issue of anti-conversion and delisting of ST status organised by JDSSM, more than 55000 tribals participated

Bihar: Row over ‘Hindu Rashtra’ banners in Darbhanga, VHP slams Nitish-Tejashwi Government for lodging FIR

Hindu Rashtra Flags: Bihar police arrested VHP district secretary after flags appeared in Darbhanga

Land For Job Scam: Tejashwi Yadav finally presented before the CBI

Land For Job Scam: Tejashwi Yadav finally presented before the CBI

Demographic Shift of Europe: Spain witnessed 10 times increase in Muslim Population in last 3 decades

Demographic Shift of Europe: Spain witnessed 10 times increase in Muslim Population in last 3 decades

Organ donation by one person can give life to 8-9 people: PM Modi in ‘Mann Ki Baat’

Organ donation by one person can give life to 8-9 people: PM Modi in ‘Mann Ki Baat’

ISRO launches India’s largest LVM3 rocket from Sriharikota

ISRO launches India’s largest LVM3 rocket from Sriharikota

Khalistani extremists abused a journalist outside Indian Embassy in Washington DC

Khalistani extremists abused a journalist outside Indian Embassy in Washington DC

Khalistan supporters threaten the Indian embassy in US

Khalistan supporters threaten the Indian embassy in US

52 years of the Bengali Hindu Genocide, still no recognition from the international community

52 years of the Bengali Hindu Genocide, still no recognition from the international community

Delisting: A way to deliver Justice

Delisting: A way to deliver Justice

  • Privacy
  • Terms
  • Cookie Policy
  • Refund and Cancellation
  • Delivery and Shipping

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies

No Result
View All Result
  • Home
  • Bharat
  • World
  • Editorial
  • Analysis
  • Opinion
  • Defence
  • Culture
  • Sports
  • Business
  • RSS in News
  • My States
  • Vocal4Local
  • Special Report
  • Sci & Tech
  • Entertainment
  • Education
  • Books
  • Interviews
  • Travel
  • Health
  • Obituary
  • Subscribe
  • Advertise
  • Circulation
  • Careers
  • About Us
  • Contact Us
  • Privacy Policy
  • Cookie Policy
  • Terms of Use
  • Refund and Cancellation

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies